Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11718)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Mar 24, 2019 (publication date) through Nov 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wimmer E, Ihrler S, Gires O, Streit S, Issing W, Bergmann C. Fibroblast growth factor receptor 4 single nucleotide polymorphism Gly388Arg in head and neck carcinomas. World J Clin Oncol 2019; 10(3): 136-148 [PMID: 30949443 DOI: 10.5306/wjco.v10.i3.136] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v10/i3/136.htm |
| Number | Citing Articles |
| 1 |
Lluvia Sugey Sosa-Quintero, Sonia Guadalupe Barreno-Rocha, Sandra Guzmán-Silahua, Grecia Guadalupe Ornelas-Ibarra, Lluvia Giselle Demis-Eliseo, Benjamín Rubio-Jurado, Arnulfo Hernán Nava-Zavala. Biomarcadores serológicos de riesgo en linfoma no Hodgkin. Salud Jalisco 2023; 10(3): 164 doi: 10.35366/113307
|
| 2 |
Muyang Chen, Tongshan Wang, Dianzhe Tian, Chaorui Hai, Zixuan Qiu. Induction, growth, drug resistance, and metastasis: A comprehensive summary of the relationship between STAT3 and gastric cancer. Heliyon 2024; 10(18): e37263 doi: 10.1016/j.heliyon.2024.e37263
|
| 3 |
Tao Peng, Yangyang Sun, Zhiwei Lv, Ze Zhang, Quanxin Su, Hao Wu, Wei Zhang, Wei Yuan, Li Zuo, Li Shi, Li-Feng Zhang, Xiaoli Zhou, Yuanyuan Mi. Effects of FGFR4 G388R, V10I polymorphisms on the likelihood of cancer. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-020-80146-y
|
| 4 |
Ju-Pi Li, Hsien-Cheng Huang, Po-Jen Yang, Chien-Yuan Chang, Yu-Hua Chao, Thomas Chang-Yao Tsao, Hsuan Huang, Yu-Ching Hung, Ming-Ju Hsieh, Shun-Fa Yang. FGFR4 Gene Polymorphism Reduces the Risk of Distant Metastasis in Lung Adenocarcinoma in Taiwan. International Journal of Environmental Research and Public Health 2020; 17(16): 5694 doi: 10.3390/ijerph17165694
|
| 5 |
Hailing Lin, Hongbo Fu, Shishen Sun, Hao Yin, Jie Yuan, Jilin Liao. Patient tissue-derived FGFR4-variant and wild-type colorectal cancer organoid development and anticancer drug sensitivity testing. Heliyon 2024; 10(10): e30985 doi: 10.1016/j.heliyon.2024.e30985
|
| 6 |
Zechen Wang, Karen S. Anderson. Therapeutic Targeting of FGFR Signaling in Head and Neck Cancer. The Cancer Journal 2022; 28(5): 354 doi: 10.1097/PPO.0000000000000615
|
| 7 |
Jung Han Kim, Soo Young Jeong, Hyun Joo Jang, Sung Taek Park, Hyeong Su Kim. FGFR4 Gly388Arg Polymorphism Reveals a Poor Prognosis, Especially in Asian Cancer Patients: A Meta-Analysis. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.762528
|
| 8 |
Abdolkarim Moazeni-Roodi, Sahel Sarabandi, Shima Karami, Mohammad Hashemi, Saeid Ghavami. An updated meta-analysis of the association between fibroblast growth factor receptor 4 polymorphisms and susceptibility to cancer. Bioscience Reports 2020; 40(10) doi: 10.1042/BSR20192051
|